ESRD patients are vulnerable to hypoglycemia due to impaired insulin clearance, glucose metabolism changes, and effects of dialysis. Hypoglycemic events lead to serious and life-threatening complications.
Aims for Improvement:
To decrease the rate of hypoglycemic events amongst ESRD patients receiving insulin for hyperkalemia treatment

Lo, MD, Anna

Mundada, MD, Rachana